Per-Anders Broliden

Phase II trial of subcutaneous anti-CD52 monoclonal antibody alemtuzumab (Campath-1H) as first-line treatment for patients with B-cell chronic lymphocytic leukemia (B-CLL)

Jeanette Lundin, Eva Kimby, Magnus Björkholm et al. · Blood · 2002 · 496 citations · Full text

Neutralizing cross-reactive and non-neutralizing monoclonal antibodies to HIV-1 gp 120

Lennart Åkerblom, Jorma Hinkula, Per-Anders Broliden et al. · AIDS · 1990 · 89 citations

Replicative capacity of HIV-2, like HIV-1, correlates with severity of immunodeficiency

Jan Albert, Anders Nauclér, Blenda Böttiger et al. · AIDS · 1990 · 49 citations

A Human Monoclonal Antibody to HIV-1 gp41 with Neutralizing Activity Against Diverse Laboratory Isolates

Joseph Cotropia, Kenneth E. Ugen, Srisakul Kliks et al. · Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology · 1996 · 43 citations

Neurovirology, Human Monoclonal Antibody, Medicine +15

Monoclonal Antibodies to Conserved Regions of the Major Core Protein ( <i>gag</i> 24) of HIV-1 and HIV-2

Emilio Carpio, Carlos A. Duarte, Jorma Hinkula et al. · AIDS Research and Human Retroviruses · 1991 · 11 citations